INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
SJ
Sumner Michael JohnChief Medical Officer
INOINOVIO PHARMACEUTICALS, INC.
Option exercise
M—
4,292 sh
Mar 31, 2026Apr 1, 2026
Page 1035 of 1742
← PrevNext →
traded Mar 31, 2026
+1d
SEC Form 4

Evidence

13
PE
Potts Charles EdwardDirector
IDAIT Stamp Inc
Grant or award
A—
1,186 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
PS
Pomerantz Jennifer S.Director
NOGNORTHERN OIL & GAS, INC.
Grant or award
A—
2,351 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
HR
Hyun RandyDirector
SPOKSpok Holdings, Inc
Grant or award
A$25K
2,294 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

13
RC
Rogers Matthew CDirector
EXCEXELON CORP
Grant or award
A$44K
878 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
GC
Gallo Ann CDirector
PIPRPIPER SANDLER COMPANIES
Grant or award
A—
323 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
SK
Segedi Bryan KDirector
EXCEXELON CORP
Grant or award
A$44K
878 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
BM
Bang Jimmy MChief Lending Officer
OPBKOP Bancorp
Option exercise
M—
1,020 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

13
MJ
Mettler JodyChief Operating Officer
BTGOBITGO HOLDINGS, INC.
Grant or award
A—
8,000 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
CB
Cree BrianPresident & Interim CEO
VTSVitesse Energy, Inc.
Grant or award
A—
54.2K sh
Mar 26, 2026Apr 1, 2026
traded Mar 26, 2026
+6dSEC Form 4

Evidence

12
WE
Washington Alex E IiiDirector
WTFCWINTRUST FINANCIAL CORP
Grant or award
A$73K
524 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

12
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$54K
1,448 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$100K
6,570 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$100K
3,878 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$100K
8,333 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
10.8K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Tax withholding
F$68K
1,809 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
790 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$100K
5,040 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
ND
Natan DavidDirector
SOWGSow Good Inc.
Grant or award
A$129K
276.9K sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
RH
Ramani HiteshChief Accounting Officer
PATHUiPath, Inc.
Tax withholding
F$59K
5,289 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

12
CE
Cunningham Gerald EdwinDirector
FINWFinwise Bancorp
Grant or award
A$50K
3,179 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

12
MK
McAleenan KevinDirector, Chief Executive Officer
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$139K
39.4K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

12
BS
Brown ShellyEVP, Chief Strategy Officer
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$100K
6,195 sh
Mar 30, 2026Apr 1, 2026
traded Mar 30, 2026
+2dSEC Form 4

Evidence

12
MK
McAleenan KevinDirector, Chief Executive Officer
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$68K
22.4K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

12
GN
Giordano James NDirector
FINWFinwise Bancorp
Grant or award
A$50K
3,179 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

11
LC
Longhito ChristopherFMR SVP & CSCO
GICGLOBAL INDUSTRIAL Co
Option exercise
M$47K
1,984 sh
Mar 27, 2026Apr 1, 2026
traded Mar 27, 2026
+5dSEC Form 4

Evidence

9
SW
Sesler Douglas WilliamDirector
MMacy's, Inc.
Grant or award
A$27K
1,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
DL
Danzey Allen LChief Financial Officer
DXYNDIXIE GROUP INC
Tax withholding
F$1,276
3,189 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
JD
Jin DavidChief Financial Officer
FBIOFortress Biotech, Inc.
Grant or award
A$6,456
2,967 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
EXPIAGNT, Inc.
Grant or award
A—
58 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
SR
Steele William Robert JrChief Financial Officer
USARUSA Rare Earth, Inc.
Grant or award
A—
63.5K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
GM
Gordon Susan M.Director
BKSYBlackSky Technology Inc.
Grant or award
A—
894 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
BN
Ballew NealCHIEF ACCOUNTING OFFICER
OHIOMEGA HEALTHCARE INVESTORS INC
Grant or award
A$6,258
168 sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

9
BC
Blankenship CarolynGeneral Counsel and Secretary
BBAIBigBear.ai Holdings, Inc.
Tax withholding
F$48K
13.6K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC Form 4

Evidence

9
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$196K
2,366 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
PL
Paterson LydiaDirector
UDMYUdemy, Inc.
Grant or award
A—
3,246 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
GP
Guerre Robert PaulSec, Dir of Corp Compliance
UFPIUFP INDUSTRIES INC
Grant or award
A$1,382
15 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence

9
VE
Vougessis EvangelineDirector
HTZHERTZ GLOBAL HOLDINGS, INC
Grant or award
A$13K
2,712 sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC Form 4

Evidence